F-Star Therapeutics Inc
(FSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,233 | -9,734 | -25,619 | -17,072 | -13,621 |
| Depreciation Amortization | 297 | 221 | 1,144 | 887 | 334 |
| Accounts payable and accrued liabilities | -2,231 | -548 | -2,847 | 677 | 1,210 |
| Other Working Capital | -3,030 | -6,644 | -5,917 | 9,748 | 5,563 |
| Other Operating Activity | 6,850 | 2,327 | 17,013 | 5,642 | 4,032 |
| Operating Cash Flow | $-23,347 | $-14,378 | $-16,226 | $-118 | $-2,482 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -643 | -252 | N/A | N/A | -62 |
| Net Acquisitions | N/A | N/A | 9,779 | N/A | N/A |
| Sale Of Investment | N/A | N/A | 5,000 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -730 | -50 | N/A |
| Other Investing Activity | 0 | 0 | -730 | -50 | 0 |
| Investing Cash Flow | $-643 | $-252 | $14,049 | $-50 | $-62 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,845 | N/A | 850 | 850 | 500 |
| Common Stock Issued | 77,293 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -92 | 0 | 15,000 | 0 | 0 |
| Financing Cash Flow | $87,046 | $N/A | $15,850 | $850 | $500 |
| Exchange Rate Effect | 52 | -216 | -48 | -56 | -201 |
| Beginning Cash Position | 18,526 | 18,526 | 4,901 | 4,901 | 4,901 |
| End Cash Position | 81,634 | 3,680 | 18,526 | 5,527 | 2,656 |
| Net Cash Flow | $63,108 | $-14,846 | $13,625 | $626 | $-2,245 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,347 | -14,378 | -16,226 | -118 | -2,482 |
| Capital Expenditure | -658 | -267 | N/A | N/A | -62 |
| Free Cash Flow | -24,005 | -14,645 | -16,226 | -118 | -2,544 |